Krio Institute Cell and Tissue Bank

What Krio Institute Cell and Tissue Bank does

Krio Institute Cell and Tissue Bank (legal name: Krio Intézet Zrt.) is a privately held Hungarian cryogenic stem cell bank headquartered in Budapest. Founded in 1998 and operating under healthcare provider registration ID 017466 with regulatory permit IF-14225-5/2012, the company specializes in the collection, processing, and long-term cryogenic storage of stem cells derived from umbilical cord blood, cord tissue, and placental blood. The institute is a wholly-owned subsidiary of the FamiCord Group, a pan-European conglomerate that the company markets as Europe's largest and the world's third largest stem cell bank network, with access to over 1 million stored samples, 1,700 cooperating hospitals across Europe, and more than 7,000 stem cell treatments performed using samples from the network.

The company's core product is its cord blood and cord tissue stem cell storage package, sold on a subscription basis with annual storage fees (a publicly referenced rate of 35,420 Ft) plus initial collection and processing fees, with promotional discounts and interest-free installment options available. It targets expectant parents through a direct-to-consumer motion: online registration, phone consultations (via +36 1 414 0130), and partnerships with hospitals and obstetricians for sample collection at birth. Beyond the core storage service, Krio operates an expanded portfolio of supplementary services including genetic laboratory tests (e.g., SMA screening), pediatric neurology, gynecology, a sperm bank and male health center, andrology, and transplant assistance — all leveraged off the core reproductive-and-childhood-health customer relationship.

Revenue mechanics are recurring subscription-based with no publicly disclosed financial figures. The company markets its differentiation primarily on FamiCord Group affiliation, scale of stored samples, the breadth of treatable indications (cited as up to 80 serious immunological and hematological diseases, plus autism treatment applications), and accreditations including ISO 9001 and memberships in EBMT, the Cord Blood Association, and Cord Blood Europe. CEO Takács Zsuzsanna (vezérigazgat\u00f3) leads a 51-100 employee organization operating in Hungary while being plugged into the FamiCord Group's pan-European, Middle Eastern, and African distribution network.

Name

Krio Institute Cell and Tissue Bank

Legal name

Krio Intézet Zrt.

Website

https://krio.hu

Company type

Private

Founded year

1998

Operating status

Operating

Headcount range

51–100 employees

Short description

Krio Institute Cell and Tissue Bank is a Budapest-based private stem cell bank that collects, processes, and cryogenically stores umbilical cord blood, cord tissue, and placental blood for expectant parents in Hungary, operating as a wholly-owned subsidiary of the pan-European FamiCord Group.

Ownership category

akta.pro rank

Product category

Stem Cell Banking / Cord Blood Storage Services

NAICS

Blood and Organ Banks (621991)

SIC

Services-Medical Laboratories (8071)

akta.pro industry

PRIMARYHLAAAGAE

Cell & Tissue Banking (biobanking, cord blood/tissue)

Healthcare & Life Sciences/Biotechnology & Biologics/Regenerative Medicine & Tissue Engineering

Keywords

• Cord blood banking
• Stem cell storage
• Tissue preservation services
• Genetic laboratory testing
• Reproductive health services

Headquarters

HQ city

Budapest

HQ country

Hungary

HQ region

Europe

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales

Revenue model

1. Stem Cell Storage Services: Recurring annual storage fees for preserved cord blood and cord tissue samples, with initial collection and processing fees

Pricing tiers

Go-to-market motion1 record

Distribution channels2 records

Marketing channels4 records

Core offering

Krio Institute Cell and Tissue Bank is a laboratory that collects, processes, and cryogenically preserves stem cells derived from umbilical cord blood, cord tissue, and placental blood for expectant parents. The core service is long-term stem cell storage under annual subscription, with supplementary offerings including genetic laboratory tests, pediatric neurology, gynecology, sperm banking, andrology, and transplant assistance services.

Product overview

Krio Institute is a family stem cell bank offering a comprehensive portfolio of cryogenic storage services centered around umbilical cord blood and tissue stem cell preservation. The core offering is stem cell storage, with supplementary services including genetic laboratory testing, pediatric neurology, gynecology, sperm banking, and andrology services. The institute operates as part of the FamiCord Group, Europe's largest stem cell bank network, providing storage packages at various price points with options for supplementary testing and premium services.

Differentiator

Problem solved

Functional benefit

Products and services

• Stem Cell Storage (Cord Blood and Cord Tissue) Collection, processing, and cryogenic long-term storage of umbilical cord blood and cord tissue-derived stem cells for expectant parents, enabling potential future medical treatments for serious diseases.
• Genetic Laboratory Tests Laboratory testing services including SMA screening and other genetic examinations performed on stored samples.
• Children's Neurology Pediatric neurology services including treatment support for neurological conditions in children.
• Gynecology Gynecology services for maternal health and related medical care.
• Sperm Bank and Male Health Center Sperm banking services and male reproductive health services including safe storage solutions for sperm samples.
• Andrology Male reproductive health diagnostic and treatment services.
• Supplementary Services Additional optional services including extended testing and premium storage options for stem cell banking clients.
• Transplant Assistance Assistance services for clients undergoing stem cell transplantation procedures.

Named customers3 records

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Three partnerships are on record, tiered core and minor.

• FamiCord GroupcoreStrategic or Co-development PartnerParent company network - Europe's largest and world's 3rd largest stem cell bank with 1,000,000+ stored samples, 1,700 cooperating hospitals, and 7,000+ stem cell treatments performed
• Czeizel IntézetcoreStrategic or Co-development PartnerStrategic partner in fetal diagnostics - leading provider in Hungary with over 25 years of experience serving nearly 200,000 families with childbearing-related examinations
• Premium EgészségpénztárminorGTM or Marketing PartnerHealth fund partner offering 10,000 Ft credit and 20% tax refund for stem cell storage contracts

Scale indicators5 records

Recent moves1 record

Expansion highlights5 records

Direct peers

• Cellaviva: Swedish and Danish cord blood bank operating within the FamiCord Group; comparable in product offering and target customer to Krio.
• Smart Cells: UK-based cord blood bank operating within the FamiCord Group; offers nearly identical subscription-based storage services and shares Krio's parent network and brand infrastructure.
• Eticur): Germany-based cord blood bank and FamiCord Group subsidiary offering the same cryogenic storage services to expectant parents in a major Western European market.
• Crioestaminal: Portuguese cord blood and tissue bank operating under the FamiCord Group; directly comparable in business model, customer base, and product offering to Krio.
• Sevibe Cells: Spanish cord blood bank and FamiCord Group subsidiary serving the Iberian market with the same DTC subscription storage model as Krio.
• Biogenis: Romanian cord blood bank within the FamiCord Group, offering identical subscription storage services to expectant parents in an adjacent Eastern European market.
• PBKM (Polski Bank Komórek Macierzystych): Poland's largest cord blood bank and a fellow FamiCord Group subsidiary; directly comparable as it operates the same network-backed cord blood and tissue storage model in an adjacent Central European market.

Broad incumbents

• Cord Blood Registry (CBR): One of the largest private cord blood banks globally; a broad incumbent with comparable subscription-based storage model but operating primarily in the US market.
• ViaCord: Established US-based private cord blood bank offering nearly identical family cord blood and tissue storage services with a long-standing DTC consumer brand.
• Cryo-Cell International: US-listed global cord blood bank with multi-decade operating history; a broad incumbent offering comparable private cord blood storage services but with deeper direct-to-consumer brand presence in North America.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/user/kriointezet
• Facebookfacebook.com/krio.hu
• Instagraminstagram.com/kriocsaladiossejtbank
• Xx.com/krio_intezet

Compliance5 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Krio Institute Cell and Tissue Bank